Amgen To Expand Puerto Rican Manufacturing Operations
This article was originally published in The Pink Sheet Daily
The initiative calls for construction of a new formulation, fill and finish facility as well as expansion of existing facilities.
You may also be interested in...
Foreign expansion effort includes new manufacturing facilities in Cork, Ireland and development of a new business entity, Amgen International.
DURHAM, N.C. - The decline in FDA's tally of new molecular entity approvals stems from fewer approvals of non-innovative products in recent years, while approvals of truly innovative products has largely held steady, according to FDA Deputy Commissioner for Policy, Planning and Preparedness Randall Lutter
Amgen's failed Anemia of Cancer trial of Aranesp and Panitumumab Advanced Colorectal Cancer Evaluation (PACCE) trial of Vectibix may illustrate the potential pitfalls facing sponsors that conduct "real world" trials of their products